Bill Aims to Protect Patient Access to Medication Information

April 3, 2023 by Dan McCue
Bill Aims to Protect Patient Access to Medication Information
Rep. Jared Golden, D-Maine

WASHINGTON — A bill introduced by Rep. Jared Golden, D-Maine, aims to ensure that rural Americans and senior citizens have access to information about their prescription medications — even without internet access.

“Many rural Mainers and seniors don’t have reliable access to the internet or aren’t comfortable using it to get important information about their prescription medications,” Golden said as he explained the motivation behind the Patients’ Right to Know Their Medication Act of 2023.

“Our bipartisan bill requires information about medications to be printed, ensuring that every American who relies on a prescription has all the information they need to take it safely when they leave the pharmacy,” he continued, adding, “This commonsense bill also would support hundreds of good jobs in Madawaska and our state’s forest products industry.” 

Joining Golden in sponsoring the bill are Reps. Buddy Carter, R-Ga., Dutch Ruppersberger, D-Md., and Bruce Westerman, R-Ark. 


Pharmacies often provide printed medication information for patients; however, they are not required to do so under current law, the representatives said.

As a result, some patients never receive important information on the safety, dosage and other details of their prescriptions with important health consequences. 


Printed information is particularly important in rural areas where internet access is often unreliable and for senior populations who don’t regularly use computers. 

The introduction of this bill also marks another step in the fight to protect the hundreds of good-paying Maine jobs at the Twin Rivers Paper Company’s Madawaska Paper Mill. 

In 2021, Golden successfully worked to defeat an amendment backed by the pharmaceutical lobby that would have required prescription drug manufacturers to distribute information electronically rather than include a paper insert. 

Twin Rivers Paper in Madawaska is the leading manufacturer of the paper inserts and employs over 500 people.


The Patients’ Right to Know Their Medication Act has been referred to the House Committee on Energy and Commerce.

Dan can be reached at [email protected] and @DanMcCue

A+
a-
  • access to information
  • Jared Golden
  • labeling
  • packaging
  • prescription drugs
  • In The News

    Health

    Voting

    Prescription Drugs

    May 25, 2023
    by Dan McCue
    Administration Floats New Rules for Drug Cost Transparency

    WASHINGTON — The Biden administration has proposed using new tools to monitor costs associated with prescription drugs so it can... Read More

    WASHINGTON — The Biden administration has proposed using new tools to monitor costs associated with prescription drugs so it can hold pharma manufacturers accountable for what Medicaid programs pay for them. The Notice of Proposed Rule Making was made through the Department of Health and Human... Read More

    May 15, 2023
    by Dan McCue
    Justices Refuse to Hear 'Skinny Label' Drug Patent Case

    WASHINGTON — The Supreme Court on Monday declined to review a 2020 decision by the U.S. Circuit Court of Appeals... Read More

    WASHINGTON — The Supreme Court on Monday declined to review a 2020 decision by the U.S. Circuit Court of Appeals for the Federal Circuit that resulted in Teva Pharmaceuticals being found liable for $235 million for infringing on a GlaxoSmithKline heart drug patent. The case placed... Read More

    Dying Patients Protest Looming Telehealth Crackdown

    At age 93, struggling with the effects of a stroke, heart failure and recurrent cancer, Teri Sheridan was ready to... Read More

    At age 93, struggling with the effects of a stroke, heart failure and recurrent cancer, Teri Sheridan was ready to end her life using New Jersey's law that allows medically assisted suicide -- but she was bedbound, too sick to travel. So last Nov. 17, surrounded... Read More

    Abortion Pill Rulings in Conflict: What Happens Next?

    WASHINGTON (AP) — The Texas case that could cut off access to the most commonly used abortion medication has started... Read More

    WASHINGTON (AP) — The Texas case that could cut off access to the most commonly used abortion medication has started on a path through the legal system that could quickly lead to the Supreme Court. The drug, mifepristone, was approved for use by the Food and... Read More

    April 3, 2023
    by Dan McCue
    Bill Aims to Protect Patient Access to Medication Information

    WASHINGTON — A bill introduced by Rep. Jared Golden, D-Maine, aims to ensure that rural Americans and senior citizens have... Read More

    WASHINGTON — A bill introduced by Rep. Jared Golden, D-Maine, aims to ensure that rural Americans and senior citizens have access to information about their prescription medications — even without internet access. “Many rural Mainers and seniors don’t have reliable access to the internet or aren’t... Read More

    March 20, 2023
    by Dan McCue
    Karuna Could Submit Schizophrenia Drug to FDA by Mid-Year

    BOSTON — Encouraged by positive topline results from its phase 3 trial for its new therapy for adults with schizophrenia,... Read More

    BOSTON — Encouraged by positive topline results from its phase 3 trial for its new therapy for adults with schizophrenia, Karuna Therapeutics announced Monday that it is on track to submit KarXT to the Food and Drug Administration for approval by summer. If that comes to... Read More

    News From The Well
    scroll top